Hypericin photodynamic therapy in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 16 Sep 2014
Price : $35 *
At a glance
- Drugs Hypericin (Primary)
- Indications Cutaneous T-cell lymphoma; Psoriasis
- Focus Adverse reactions
- Sponsors HY BIOPHARMA
- 16 Sep 2014 New trial record
- 05 Sep 2014 Results published in the Media Release.